X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

    Once More, M&As In Biotechechnology Industry Are Thriving

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

    Once More, M&As In Biotechechnology Industry Are Thriving

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Sanofi Drug Components Venture Comes To Life After Two Years

Content Team by Content Team
10th May 2022
in News
Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19

It’s a fact: EUROAPI debuted on the Euronext exchange two years and one pandemic after Sanofi announced plans to sell off its European pharma ingredients division. Even though the market as a whole was going down, shares of the new company that makes active pharmaceutical ingredients were up more than 3% in early trading.

EUROAPI prides itself on being a leading player in the API world. COVID-19 and, more lately, the war in Ukraine have exposed holes in the global pharmaceutical supply chain, prompting its debut. Many of the substances used by the pharmaceutical businesses are produced in China and India. EUROAPI wants to be the go-to partner for all pharma and biotech companies. It has stated previously that it considers itself the world’s top small molecule manufacturer and the second biggest API company by revenue.

As per EUROAPI, the Sanofi offshoot has a library of about 200 APIs that it sells to many more than 500 customers spread across 80 countries. EUROAPI employs around 3,350 people across six state-of-the-art manufacturing and development centres that are spread in Hungary, France, Germany, Italy, and the United Kingdom.

In a statement, Karl Rotthier, the business’s CEO, stated that by operating as an independent company, EUROAPI will gain freedom and development potential to strengthen its role as a trusted partner for all pharma and biotech enterprises.

EUROAPI is still owned by Sanofi, which holds a 30% share.

The company aims to produce 1 billion euros in revenue in 2022, up from 893 million euros last year. The API process development and manufacturing market, which was worth 72 billion euros (about $76.1 billion) in 2019, is likely to expand at a rate of 6% to 7% per year until 2024, as per EUROAPI. During the same period, the worldwide contract manufacturing and development industry is forecasted to rise at a rate of 7% to 8% yearly.

EUROAPI announced four goals on its strategic route map to grab the API industry as part of its public listing announcement. According to EUROAPI, the firm wants to speed up its work as a CDMO, enhance its existing product line, grow its technical platforms with visibility through distinct and sophisticated APIs, and improve operational efficiencies. Sanofi debuted its API spinoff in 2020, as CEO Paul Hudson set out on a mission to cut 2 billion euros from the company’s yearly expenses by 2022.

After having joined the French drug giant in 2019, the CEO implemented a play to win approach, which included emphasising growth sectors above struggling illness areas.

Previous Post

Quality Issues Lead To Novartis Halting Cancer Radiotherapy

Next Post

In DELIVER Phase III Study, Farxiga Achieved Primary Outcome

Related Posts

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
FDA Approvals

Food And Drug Administration User Fee Has Been Reauthorized

3rd November 2022
Clinical Trials

Cancer Clinical Trials Get A Brand New Platform In Melbourne

3rd November 2022
Next Post
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

In DELIVER Phase III Study, Farxiga Achieved Primary Outcome

Latest News

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
FDA Approvals

Food And Drug Administration User Fee Has Been Reauthorized

3rd November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In